客服
电话
17710328343
微信
扫一扫添加
回到顶部
| 产品编号： | EBST-02 |
|---|---|
| 英文名称： | 4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-[1,1'-biphenyl]-2-carbonitrile |
| CAS： | 138401-24-8 |
| 分子式： | C25H27N3O |
| 分子量： | 385.50 |
| 中文名称 | 厄贝沙坦02 |
|---|---|
| 中文别名 | 厄贝沙坦烃化物;4'-[(2-丁基-4-氧-1,3-二氮杂螺环[4.4]壬-1-烯-3-基)甲基]联苯-2-甲腈;2-丁基-3-[[2'-氰基-[1,1'-联苯]-4-基]甲基]-1,3-二氮杂螺[4,4]壬-1-烯-4-酮;2-丁基-3-[[2 -氰基-[1,1 -联苯]-4-基]甲基]-1,3-二氮杂螺[4,4]壬-1-烯-4-酮;3-氰基-2-(三丁基锡)吡啶;4'-[(2-丁基-4-氧-1,3-二氮杂螺[4,4]壬-1-烯-3-基)甲基]-[1,1'-联苯]-2-腈;4'-[(2-正丁基-4-氧-1,3-二氮杂螺环[4,4]壬-1-烯-3-基)甲基]-[1,1'-联苯]-2-甲腈;4’-[(2-丁基-4-氧-1,3-二氮杂螺环[4.4]壬-1-烯-3-基)甲基]联苯-2-甲腈;厄贝沙坦氰基杂质;夫西地酸;4'-[(2-正丁基-4-氧-1,3-二氮杂螺环[4.4]壬-1-烯-3-基)甲基]-[1,1'-联苯]-2-甲腈;厄贝烃化物盐酸盐;4'-[(2-丁基-4-氧代-1,3-二氮杂螺[4,4]壬-1-烯-3-基)甲基]-[1,1'-联苯]-2-甲腈 |
| 英文名称 | 4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-[1,1'-biphenyl]-2-carbonitrile |
| 英文别名 | 4'-((2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-[1,1'-biphenyl]-2-carbonitrile;4'-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-(1,1'-biphenyl)-2-carbonitrile;[1,1'-Biphenyl]-2-Carbonitrile-4-[(2-Butyl-4-Oxo-1,3-Diazaspiro[4.4]Non-1-en-3-yl) Methyl];4'-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]biphen biphenyl-2-carbonitrile;2-Butyl-3-[[2'-cyano-[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4,4]non-1-en-4-one;[1.1′-Biphenyl]-2-carbonitrile-4-[(2-butyl-4-oxo-1.3-diazaspiro[4.4]non-1-en-3-yl)methyl];4'-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-[1,1'-Biphenyl]-2-carbonitrile;CyanoIrbesartan;4'-[(2-Butyl-4-oxo-1,3-diazaspiro[4,4]non-1-en-3-yl)methyl]-[1,1'-biphenyl]-2-carbonitrile;4'-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]biphenyl-2-carbonitrile;[1,1'-Biphenyl]-2-carbonitrile, 4'-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-;4'-[(2-n-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-[1,1'-biphenyl]-2-carbonitrile;4'-[(2-N-BUTYL-4-OXO-1,3-DIAZAS;4'-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl][1,1'-biphenyl]-2-carbonitrile;2-Butyl-3-[[2'-cyano-[1,1;[1,1'-Biphenyl]-2-carbonitrile, 4'-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-; 1,3-Diazaspiro[4.4]nonane, [1,1'-biphenyl]-2-carbonitrile deriv.; 2-Butyl-3-[[2'-(cyano)biphenyl-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one; 4'-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl][1,1'-biphenyl]-2-carbonitrile;Irbesartan Cyano Impurity;4'-[(2-BUTYL-4-OXO-1,3-DIAZASPIRO[4.4]NON-1-EN-3-YL)METHYL]-(1,1'-BIPHENYL)-2-CARBONITRILE;4''-(2-Butyl-4-oxo-1,3-diaza-spiro[4.4]non-1-en-3-ylmethyl)-biphenyl-2-carbonitrile;4'-[(2-butyl-4-oxo-1,3-diazaspiro[4,4]non-1-en-3-yl)methyl]-[1,1'-biphenyl]-2-carbonitrile;BDBM50042242;MFCD06658242;4'-((2-butyl-4-oxo-1,3-diazaspiro(4.4)non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile;4'-((2-n-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-(1,1'-biphenyl)-2-carbonitrile;Irbesartan impurity 12;4'-[[2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3yl]methyl][1,1'-biphenyl]-2-carbonitrile;AC-20377;AS-13565;4'-[[2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl]methy][1,1'-biphenyl]-2-carbonitrile;KWEQEHOPDHARIA-UHFFFAOYSA-N;2-[4-[(8-butyl-6-oxo-7,9-diazaspiro[4.4]non-8-en-7-yl)methyl]phenyl]benzonitrile;J-007132;S11999;CHEMBL332051;2-(n-butyl)-3-[[2'-(cyano)biphenyl-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one;B4143;SCHEMBL1316335;CS-0324405;2-n-butyl-3-[[2'-cyanobiphenyl-4-yl]methyl]-1,3-diazaspiro-[4.4]non-1-en-4-one;FT-0601482;4'-((2-n-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-[1,1'-biphenyl]-2-carbonitrile;BCP13496;[1,1'-Biphenyl]-2-carbonitrile,4'-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl];4'-[(2-N-BUTYL-4-OXO-1,3-DIAZASPIRO[4.4]NON-1-EN-3-YL)METHYL]-(1,1'-BIPHENYL)-2-CARBONITRILE;A807385;4''-(2-butyl-4-oxo-1,3-diaza-spiro[4,4]-n... |
| CAS号 | 138401-24-8 |
| 分子式 | C25H27N3O |
| 摩尔分子量 | 385.50 |
| 用途 | 仅用于药物研发试验中相关物质的鉴定及鉴别 |